Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded a new revision tag 'Revision: v3.6.3' to the study record history. The previous revision tag 'Revision: v3.6.2' is removed from the current history view.SummaryDifference0.1%

- Check10 days agoChange DetectedThe history now includes a new page revision labeled v3.6.2, replacing the previous v3.6.0 entry.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status updated to indicate no more participants are being sought. A new Revision: v3.6.0 was added and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.5%

- Check32 days agoChange DetectedThe history entry now shows the latest revision as v3.5.5, replacing the previous v3.5.4. This is a minor version update in the page's history and does not change the study data or visible content.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer now shows a revision label of v3.5.4, indicating a new release build.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry (v3.5.3) was added to the study record history, replacing the previous revision (v3.5.2). This reflects a platform/version update rather than any change to the trial content.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.